Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001376043-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 16, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
30,000
Total Value
$765,947.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 12, 2026 | Exercise/Conversion | 10,000 | $26.52 | $265,200.00 | 66,250 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 12, 2026 | Sale | 10,000 | $50.07 | $500,747.00 | 56,250 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 12, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |